Corresponding author: Professor J. R. Tagg (e-mail: john.tagg@stonebow.otago.ac.nz). ‡Present address: Department of Oral Sciences and Orthodontics, School of Dentistry, University of Otago, Dunedin, New Zealand.
Bacteriocins produced by mutans streptococci are known as mutacins. In this study 16 broadly active mutacin-producing Streptococcus mutans strains from New Zealand, North America and Europe were classified into four groups (A–D) on the basis of differences in their activity in deferred antagonism tests against either the homologous producer strain (to test for presence of self-immunity) or indicator strains Staphylococcus aureus 46 and Enterococcus faecium TE1. Two of the strains included in the study (UA140 and UA96) were representatives of the group I and II mutacin producer strains previously described by Caufield and co-workers. One of the New Zealand isolates of group A (S. mutans strain N) appeared to produce inhibitory activity similar to that of the group I prototype strain UA140. Four other New Zealand isolates of group B (S. mutans strains M19, M34, B34 and D14) had mutacin II-like activity. The group B mutacin producers differed from the group A mutacin producers in their additional activity against Staph. aureus 46. Seven S. mutans strains (M46, B46, B57, M12, M28, B28 and 13M) were distinguished from the group A and group B mutacin producers in that they inhibited E. faecium TE1. These were called group C mutacin producers. Strains H7 and H23 resembled the group C strains in their action on both indicator strains TE1 and 46. However, these two strains failed to exhibit immunity to their own inhibitory products in the deferred antagonism test and were separately classified as group D mutacin producers. Phylogenetic analysis of the strains by several genotypic and phenotypic characteristics revealed that the mutacin groups were associated with distinct evolutionary lineages of S. mutans.
BratthallD. The global epidemiology of mutans streptococci. In
JohnsonNW.
ed Dental caries. Risk markers for oral diseasesvol ICambridge Cambridge University Press; 1991287–312
BerkowitzRJ,
JonesP. Mouth-to-mouth transmission of the bacterium Streptococcus mutans between mother and child. Arch Oral Biol1985; 30:377–379[CrossRef]
CrooksM,
JamesSM,
TaggJR.
Relationship of bacteriocin-like inhibitor production to the pigmentation and hemolytic activity of mutans streptococci. Zentralbl Bakteriol Mikrobiol Hyg A1987; 263:541–547
AlaluusuaS,
TakeiT,
OoshimaT,
HamadaS. Mutacin activity of strains isolated from children with varying levels of mutans streptococci and caries. Arch Oral Biol1991; 36:251–255[CrossRef]
GrönroosL,
SaarelaM,
MättöJ,
Tanner-SaloU,
VuorelaA,
AlaluusuaS. Mutacin production by Streptococcus mutans may promote transmission of bacteria from mother to child. Infect Immun1998; 66:2595–2600
CaufieldPW,
ChildersNK,
AllenDN,
HansenJB. Distinct bacteriocin groups correlate with different groups of Streptococcus mutans plasmids. Infect Immun1985; 48:51–56
CaufieldPW,
ChildersNK,
AllenDN. et al. Plasmids in Streptococcus mutans : usefulness as epidemiological markers and association with mutacins. In
HamadaS,
MichalekSM,
KiyonoH,
MenakerL,
McGheeJR.
eds Molecular microbiology and immunobiology of Streptococcus mutans . Amsterdam: Elsevier Science Publishers; 1986217223
QiF,
ChenP,
CaufieldPW. Purification and biochemical characterization of mutacin I from the group I strain of Streptococcus mutans , CH43, and genetic analysis of the mutacin I biosynthesis genes. Appl Environ Microbiol2000; 66:3221–3229[CrossRef]
NovákJ,
CaufieldPW,
MillerEJ. Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans . J Bacteriol1994; 176:4316–4320
QiF,
ChenP,
CaufieldPW. Purification of mutacin III from group III Streptococcus mutans UA787 and genetic analyses of mutacin III biosynthesis genes. Appl Environ Microbiol1999; 65:3880–3887
QiF,
ChenP,
CaufieldPW. The group I strain of Streptococcus mutans , UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV. Appl Environ Microbiol2001; 67:15–21[CrossRef]
TaggJR,
BannisterLV.
`Fingerprinting’ β-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol1979; 12:397–411[CrossRef]
BalakrishnanM,
SimmondsRS,
TaggJR.
Diverse activity spectra of bacteriocin-like inhibitory substances having activity against mutans streptococci. Caries Res2001; 35:75–80[CrossRef]
van Palenstein HeldermanWH,
IjsseldijkM,
Huis in 'T VeldJHJ. A selective medium for the two major subgroups of the bacterium Streptococcus mutans isolated from human dental plaque and saliva. Arch Oral Biol1983; 28:599–603[CrossRef]
KilianM,
MikkelsenL,
HenrichsenJ. Taxonomic study of viridans streptococci: description of Streptococcus gordonii sp.nov. and emended descriptions of Streptococcus sanguis (White and Niven 1946), Streptococcus orali s (Bridge and Senath 1982) and Streptococcus mitis (Andrewes and Horder 1906). Int J Syst Bacteriol1989; 39:471–484[CrossRef]
HelmigR,
UldbjergN,
BorisJ,
KilianM. Clonal analysis of Streptococcus agalactiae isolated from infants with neonatal sepsis or meningitis and their mothers and from healthy pregnant women. J Infect Dis1993; 168:904–909[CrossRef]
SelanderRK,
CaugantDA,
OchmanH,
MusserJM,
GilmourMN,
WhittamTS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol1986; 51:873–884
Van LoverenC,
BuijsJF,
ten CateJM.
Similarity of bacteriocin activity profiles of mutans streptococci within the family when the children acquire the strains after the age of 5. Caries Res2000; 34:481–485[CrossRef]
WeerkampA,
VogelsGD,
SkotnickiM. Antagonistic substances produced by streptococci from human dental plaque and their significance in plaque ecology. Caries Res1977; 11:245–256[CrossRef]
HamadaS,
OoshimaT. Inhibitory spectrum of a bacteriocinlike substance (mutacin) produced by some strains of Streptococcus mutans . J Dent Res1975; 54:140–145[CrossRef]
CaufieldPW,
ShahG,
HollingsheadSK,
ParrotM,
LavoieMC. Evidence that mutacin II production is not mediated by a 5.6-kb plasmid in Streptococcus mutans . Plasmid1990; 24:110–118[CrossRef]
CaufieldPW,
ShahGR,
HollingsheadSK. Use of transposon Tn916 to inactivate and isolate a mutacin-associated gene from Streptococcus mutans . Infect Immun1990; 58:4126–4135
WoodruffWA,
NovákJ,
CaufieldPW. Sequence analysis of mutA and mutM genes involved in the biosynthesis of the lantibiotic mutacin II in Streptococcus mutans . Gene1998; 206:37–43[CrossRef]
BalakrishnanM. Purification and characterisation of mutacins produced by different clusters of inhibitory mutans streptococci. PhD thesis University of Otago; Dunedin, New Zealand: 1998